Patenting genes: balancing public health and private interest

The United States Supreme Court heard arguments Monday on whether it should be possible to patent human genes. It’s a ruling that could have an enormous impact on medical research and business around the world, as many companies already own some very lucrative patents.

Afficher le reportage au complet